<i>In Vitro</i> Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
Boudewijn L. M. de Jonge(Pfizer (United States)), Wright W. Nichols(AstraZeneca (United States)), Douglas J. Biedenbach, Krystyna M. Kazmierczak(Indiana University Bloomington), James A. Karlowsky, Daniel F. Sahm(Micro Focus (United States))
Cited by 158
Related Papers
Prevalence in the United States of <i>aac(6</i> ′ <i>)</i> - <i>Ib</i> - <i>cr</i> Encoding a Ciprofloxacin-Modifying Enzyme
|Antimicrobial Agents and Chemotherapy|2006|749
Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
|Emerging infectious diseases|1998|732
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
|Annals of Clinical Microbiology and Antimicrobials|2006|384
Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of <i>Escherichia coli</i> from Female Outpatients in the United States
|Antimicrobial Agents and Chemotherapy|2002|369
Antimicrobial Resistance Among Uropathogens that Cause Community‐Acquired Urinary Tract Infections in Women: A Nationwide Analysis
|Clinical Infectious Diseases|2001|361